Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On March 2, 2026, Tyra Biosciences, Inc. issued a press release announcing its financial results for the year end
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release Issued on March 2, 2026 104 Cover Page Interactive Data File (embedde